Preclinical

Horizon Discovery teams with UK hospital, EMQN to develop NIPT reference material

01-Apr-2019 By Melissa Fassbender

Horizon Discovery is working with St George’s University Hospital and EMQN to develop reference material for non-invasive prenatal testing, which is being increasingly adopted in the UK and abroad.

CROs ink exclusive partnership ‘to rapidly advance the field of otic research’

01-Apr-2019 By Melissa Fassbender

Sinclair Research and Turner Scientific sign an exclusive partnership through which the CROs will offer ototoxicity testing services – and improve regulatory guidance regarding the ears to protect patients, says company executive.

New consultancy targets ‘expansive global landscape’ for cell and gene therapies

01-Apr-2019 By Melissa Fassbender

Cell One Partners formally launches its consulting services and aims to be a long-term partner to its clients, supporting the development of cell and gene therapies – a market which raised more than $13.3bn in 2018.

People on the Move: Outsourcing-Pharma roundup March ‘19

29-Mar-2019 By Melissa Fassbender

The industry in March saw new c-suite appointments at CRF Bracket, PCI Pharma Services, George Clinical, and Paragon Bioservices – as well as moves to boost medical device and DMPK services at Premier Research and Sygnature Discovery, respectively.

Abzena creates offering for drug candidate optimization

29-Mar-2019 By Maggie Lynch

Abzena launches a developability assessment and optimization service to assist customers in selecting and developing lead candidates for manufacture.

Enamine, Lundbeck extend multi-year CNS drug discovery deal

28-Mar-2019 By Melissa Fassbender

Lundbeck extends its research collaboration with the drug discovery services provider Enamine to help “intensify its search for quality lead compounds.”

On a Mission: LabCorp taps single cell-sequencing tech to accelerate drug development

28-Mar-2019 By Melissa Fassbender

LabCorp’s collaboration with Mission Bio will use single cell-sequencing technology to understand the genetics of rare cell populations, which could be key to making clinical trials successful, says CEO.

‘The UK may no longer be a country where bioanalytical innovation is feasible,’ says CRO on Brexit

28-Mar-2019 By Melissa Fassbender

Clinical trials in the UK are reportedly declining as the country grapples with Brexit – a change which could make access to preclinical and bioanalytical research materials, including NHPs, problematic, says QPS.

Evotec to discover and develop first-in-class oncology therapeutics in research tie-up

26-Mar-2019 By Melissa Fassbender

Evotec AG is partnering with the Mark Foundation for Cancer Research to discover and develop first-in-class therapeutics in oncology using its new drug discovery platform.

Cellesce scales organoid production for drug discovery using proprietary bioprocessing tech

26-Mar-2019 By Melissa Fassbender

Using its proprietary bioprocessing technology, Cellesce is scaling the production of breast organoids for drug discovery research – with plans to expand into other areas of unmet medical need, says CEO.

Trianni mouse model tapped for HIV vaccine research

25-Mar-2019 By Maggie Lynch

Trianni and San Diego Biomedical Research Institute enter license agreement for the use of the Trianni Mouse in HIV vaccine research.

WuXi STA tapped as preferred partner for Beta Pharma

21-Mar-2019 By Melissa Fassbender

WuXi STA becomes the preferred CDMO partner for Beta Pharma as the company launches a Phase II clinical trial in China and begins preclinical research for an additional target.

‘Better decisions and shorter project timelines’: Optibrium taps InfoChem to up offering

19-Mar-2019 By Melissa Fassbender

Optibrium develops software for drug discovery and today announces a collaboration with InfoChem GmbH, a cheminformatics company, to provide users with a computer-aided synthesis design tool.

Clinipace implements eTMF solutions from TransPerfect

19-Mar-2019 By Maggie Lynch

Clinipace taps TransPerfect for interactive trial solutions to develop a responsive infrastructure for clinical research.

Evotec targeting AMR through new public-private partnership

19-Mar-2019 By Melissa Fassbender

Evotec is partnering with a global non-profit research group to develop a pipeline of novel antibiotics after integrating Sanofi’s infectious disease unit last year.

SenzaGen inks agreement with CRO to expand in vitro testing

18-Mar-2019 By Melissa Fassbender

In response to a growing interest in alternative testing methods, SenzaGen signs a license agreement with MB Research Labs to expand the use of its animal-free testing platform.

Charles River licenses rodent model for global diabetes reserach

14-Mar-2019 By Maggie Lynch

Charles River Labs enters a licensing agreement with Crown Bioscience to expand access to the latter’s diabetic rat model.

Funding for TriNetX totals $102m as the network expands globally

13-Mar-2019 By Maggie Lynch

TriNetX receives a total of $102m in a $40m Series D financing round as it continues to expand globally – looking to ‘spark a revolution,’ says CEO.

Preclinical CROs partner to provide GLP ototoxicity testing services

12-Mar-2019 By Melissa Fassbender

Sinclair Research and Turner Scientific sign an exclusive partnership through which the preclinical CROs will offer GLP ototoxicity testing services.

Drug development research agreement leverages simulation platform

12-Mar-2019 By Maggie Lynch

Drug development advisory firm Rosa & Co. enters research agreement with Chugai pharmaceutical to provide access to PhysioPD research services for translational biology.

Regeneron releases ‘big data’ resource for global health research

11-Mar-2019 By Maggie Lynch

Regeneron and UK Biobank announce human sequencing data resource for global research and to accelerate improved patient care through outcome algorithms.

Shyft Analytics bolsters RWE solutions

07-Mar-2019 By Melissa Fassbender

Medidata’s Shyft expands its real-world data services to meet the various real-world evidence needs of its customer’s organizations, says new VP.

People on the Move: Outsourcing-Pharma roundup February ‘19

01-Mar-2019 By Melissa Fassbender

Parexel boosts its oncology team, Premier Research has a new COO joining from PPD, and SGS names a new biologics manager, among other new hires in February.

Icon nabs molecular diagnostic lab to support precision medicine programs

26-Feb-2019 By Melissa Fassbender

Icon acquired the molecular diagnostic laboratory MolecularMD to further support precision medicine programs across all development phases.

Altasciences eyes early development space, CDMO addition

26-Feb-2019 By Melissa Fassbender

Consolidating its businesses under one brand, Altasciences is transitioning to an early drug development CRO – and looking to add a CDMO to manufacture drugs up to Phase II volumes.

SCOPE 2019

Sites challenged with fragmented processes that ‘drain resources’

21-Feb-2019 By Maggie Lynch

Clinical trial sites are challenged by fragmented financial processes, according to a new study by the Society of Clinical Research sites and Greenphire released this week at SCOPE 2019.

Lonza uses its ‘global footprint’ in hematopoietic commercialization agreement

21-Feb-2019 By Maggie Lynch

Lonza enters private label partnership to manufacture and globally commercialize AllCell’s hematopoietic primary cells to provide greater access to researchers.

‘Just a few mouse clicks’: TriNetX offers RWD analytics

21-Feb-2019 By Maggie Lynch

Global health research network, TriNetX, has added an analytic self-service offering for simplified analysis of real-world data.

PPD signs exclusive agreement with China-based AI company

21-Feb-2019 By Melissa Fassbender

PPD’s agreement with China-based Happy Life Tech focuses on site selection, patient recruitment, and real-world evidence generation for customers globally.

SCOPE 2019

Oracle integrates Quorum IRB tech to smooth submission process

19-Feb-2019 By Melissa Fassbender

The collaboration between Quorum Review IRB and Oracle goBalto removes the need to send IRB submission documents manually.

LabNetwork reaches European customers through marketplace collaboration

19-Feb-2019 By Maggie Lynch

Chemspace and LabNetwork, both online marketplaces, are to collaborate to extend their global reach in the online marketplace.

Charles River to acquire Citoxlab, M&A ‘a top priority’

14-Feb-2019 By Melissa Fassbender

Charles River is set to acquire Citoxlab for €448m ($510m) in cash, a deal which would bolster the CRO’s safety assessment portfolio to support its long-term organic growth aspirations, says CEO.

Update

Iqvia quietly purchased UK-based NLP provider Linguamatics

12-Feb-2019 By Melissa Fassbender

Iqvia acquired UK-based Linguamatics in January 2019 as part of the company's commitment to deliver value from artificial intelligence and machine learning.

Ligand and Genagon ink drug development agreement

12-Feb-2019 By Maggie Lynch

Ligand Pharmaceuticals enters an agreement with Genagon to provide access to its drug development platform capable of producing fully human antibodies.

Ncardia speeds up drug discovery with iPSC platform

11-Feb-2019 By Maggie Lynch

Preclinical CRO Ncardia’s drug screening platform enables researchers to access human disease-relevant biology for drug discovery.

People on the Move: Outsourcing-Pharma roundup January '19

08-Feb-2019 By Melissa Fassbender

People on the move in January include new CEOs at Lonza, Taconic, MaSTherCell, Pii, and Wasdell, among several other c-suite shakeups and new hires as the industry kicks off the New Year.

German biotech opens US office to expand its global presence

05-Feb-2019 By Maggie Lynch

Sirion Biotech has opened a US-based office to support local gene therapy research and clinical development with viral vector contract manufacturing.

Exclusive interview

QPS triples translational medicine capacity to support gene therapy demand

05-Feb-2019 By Melissa Fassbender

QPS is expanding ‘aggressively’ at its US-based headquarters, rebuilding on a rolling basis to support a growing demand for gene therapy treatments, says VP.

Aetion expanding RWE platform backed by $63m investment

05-Feb-2019 By Maggie Lynch

Aetion aims to advance the adoption of and standards for real-world evidence backed by a strategic investment from several global biopharma and health care companies.

Sharp’s relocation: ‘Reduces the risks, costs, and supply chain complexity’

04-Feb-2019 By Maggie Lynch

Sharp completes its relocation to its $23m facility in Pennsylvania after making additional investments to integrate services at the site.

A Game of Partnerships: How does the BMS-Celgene merger affect the CRO space?

01-Feb-2019 By Melissa Fassbender

CRO stock prices fell initially following the news that Bristol-Myers Squibb was acquiring Celgene in a deal valued at $74bn. However, is 2019’s first mega-merger really a threat to service providers?

Repositive’s ‘personal shopper’ aims to ease access to its cancer models

31-Jan-2019 By Maggie Lynch

Repositive adds a personal shopper service to its platform which holds a directory of cancer models from 14 CROs – with expansion ongoing, says CEO.

Advent invests in global CRDO BioDuro

31-Jan-2019 By Maggie Lynch

Advent private equity invests in BioDuro through a partnership as the latter aims to grow its research and drug development offerings.

Certara updates PBPK simulator to enable more realistic case modeling

31-Jan-2019 By Melissa Fassbender

Certara launches version 18 of its physiologically-based pharmacokinetic (PBPK) Simcyp Simulator with new features including advanced food staggering and tumor models to optimize trial design and dose selection.

Sanofi: NLP text mining and other AI tech to advance findings, improve data use

30-Jan-2019 By Melissa Fassbender

Real world evidence extraction is one area where Sanofi is using NLP text mining, a technology with applications across the R&D pipeline, from target identification to clinical trial design and pharmacovigilance.

Amsbio adds experimental cell lines to CAR-T services lineup

29-Jan-2019 By Maggie Lynch

Amsbio is adding experimental cell lines to its CAR-T cell services to meet an increasing demand for the technology, according to the UK-based provider.

WCG acquires CTMS internet platform for its growing network

29-Jan-2019 By Maggie Lynch

WCG acquires Velos’ CTMS internet platform to provide drug development and research management to its large institutional research network.

Horizon adds CRISPR screening service using ex vivo cells

24-Jan-2019 By Maggie Lynch

Horizon Discovery expands its CRISPR screening services to meet the requirements of immunology-based research in drug discovery.

LabConnect’s GSPN could lower sample preparation risk

24-Jan-2019 By Maggie Lynch

The new service from LabConnect, a central laboratory and support services provider, offers a global solution for sample preparation and processing requirements.

Collaboration takes aim at abuse-deterrent drugs and formulations

21-Jan-2019 By Melissa Fassbender

PinneyAssociates and NMS Labs will plan, conduct, and analyze in vitro laboratory testing of pharmaceutical formulations to evaluate any abuse-deterrent properties, says CMO.